Researchers set out to determine whether cancer-related cognitive impairment impacts older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy.
After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.
In her presentation at the 48th ONS Congress, in San Antonio, Texas, Gayle Somerstein, RN, OCN, BSN, MPH, MBA, reviews common adult learning styles that can be tailored to each patient’s individualized...
This COVID-19 roundup includes coverage of the FDA’s simpler vaccination schedule and authorization of new treatment, decline in pediatric asthma diagnoses during pandemic, and a new treatment combination...
In a multicenter, randomized, open-label, phase 3 trial, researchers set out to determine whether an advanced surgical therapy, isolated hepatic perfusion, could improve outcomes among previously untreated...
To guide prevention efforts for fatal poisonings in pediatric patients, the authors of a recent study examined characteristics of death from poisoning in young children within the United States.
Hypercholesterolemia and diabetes have a minimal impact on major adverse cardiovascular events (MACE) risk in patients with prostate cancer (PCa) who are treated with androgen deprivation therapy (ADT),...
To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...
